Karnofsky performance status

Functional status (0–100 %) with ECOG equivalent

Sources last checked: 2026-10-13

Karnofsky performance status

Functional status (0–100 %) with ECOG equivalent

Which description fits best?
Fill in every field to see the result.

The KPS→ECOG mapping is the commonly used comparison shown by ECOG-ACRIN, not a validated conversion; other published mappings place the boundaries differently.

Source: Karnofsky DA, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod CM, ed. Evaluation of Chemotherapeutic Agents. Columbia University Press; 1949:191-205. Scale text and ECOG comparison as published by ECOG-ACRIN.Open

Interpretation

0 — dead (ECOG 5)ECOG equivalent 5.
10–20 — ECOG 4Moribund or very sick; at 20 the scale describes hospital admission and active supportive care as necessary.
30–40 — ECOG 3Disabled; needs special care and assistance.
50–60 — ECOG 2Needs occasional to considerable assistance.
70–80 — ECOG 1Self-caring; normal activity only with effort or not possible.
90–100 — ECOG 0Normal activity with at most minor symptoms.

What is the Karnofsky performance status?

The Karnofsky Performance Status (KPS) rates functional ability in 10-point steps from 100 (normal, no evidence of disease) to 0 (dead). It was introduced by Karnofsky and Burchenal in 1949 to evaluate chemotherapy and remains widely used in neuro-oncology, radiotherapy and palliative care. This tool also shows the ECOG grade that ECOG-ACRIN lists alongside each KPS level.

When to use it

  • When a protocol or score asks for KPS rather than ECOG (e.g. many neuro-oncology and radiotherapy pathways)
  • To describe functional status with finer steps than the six-level ECOG scale
  • To translate between KPS and ECOG when comparing trial populations

When not to use it

  • As a precise conversion to ECOG for eligibility decisions — check the protocol's own definition
  • In children, where the Lansky play-performance scale is used instead

How it is calculated

CriterionPoints
Which description fits best?
100 — Normal, no complaints, no evidence of disease100
90 — Normal activity; minor signs or symptoms90
80 — Normal activity with effort; some signs or symptoms80
70 — Cares for self; unable to carry on normal activity or active work70
60 — Requires occasional assistance; cares for most personal needs60
50 — Requires considerable assistance and frequent medical care50
40 — Disabled; requires special care and assistance40
30 — Severely disabled; hospital admission indicated, death not imminent30
20 — Very sick; hospital admission and active supportive care necessary20
10 — Moribund10
0 — Dead0

Clinical pearls and limitations

  • The KPS→ECOG mapping is the commonly used comparison shown by ECOG-ACRIN, not a validated conversion; other published mappings place the boundaries differently.
  • The scale moves in steps of 10; intermediate values are not defined.
  • 70 marks the point at which a patient can no longer work or carry on normal activity but still cares for themselves.
  • Several KPS→ECOG mappings exist; the one shown here is the comparison published by ECOG-ACRIN.

Frequently asked questions

What is a Karnofsky score of 70?

The patient cares for themselves but cannot carry on normal activity or do active work. ECOG-ACRIN places it alongside ECOG 1.

Is Karnofsky 50 the same as ECOG 2?

In the ECOG-ACRIN comparison KPS 50–60 corresponds to ECOG 2, but the descriptions are not identical — KPS 50 already implies considerable assistance.

Which is better, Karnofsky or ECOG?

Neither is more valid in general. Use the scale your protocol, trial or score was built on; ECOG is more common in medical oncology.

Evidence and guidelines

  1. Primary source: Karnofsky DA, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod CM, ed. Evaluation of Chemotherapeutic Agents. Columbia University Press; 1949:191-205. Scale text and ECOG comparison as published by ECOG-ACRIN.
  2. Oken MM et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982;5(6):649-655.

Have a follow-up question?

Medelix answers clinical questions from current guidelines and studies — every statement with its source.

Ask Medelix about the Karnofsky performance status

Related calculators

Embed this calculatorFree to use on your website, intranet or teaching page. Copy the code below.
<iframe src="https://medelix.ai/en/embed/karnofsky" title="Karnofsky performance status – Medelix" width="100%" height="620" style="border:0;max-width:720px" loading="lazy"></iframe> <p><a href="https://medelix.ai/en/calculators/karnofsky-performance-status">Karnofsky performance status calculator by Medelix</a></p>

For healthcare professionals and medical students. These tools support, and do not replace, clinical judgement. Always check results against the original source and your local protocols.